Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 25.14
+3.37 (15.46%)
At close: Sep 2, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 2.88 billion as of September 5, 2025. Its market cap has increased by 28.86% in one year.
Market Cap
2.88B
Enterprise Value
2.74B
Revenue
418.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.14
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 2.88B, an increase of 15,958.48%. That is a compound annual growth rate of 26.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 2.88B | 54.21% |
| Dec 31, 2024 | 1.87B | -27.60% |
| Dec 29, 2023 | 2.58B | -27.67% |
| Dec 30, 2022 | 3.57B | -30.28% |
| Dec 31, 2021 | 5.12B | -11.38% |
| Dec 31, 2020 | 5.77B | 20.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 189.00B |
| GSK plc | 59.17B |
| Haleon | 32.87B |
| Smith & Nephew | 12.25B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.82B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.81B |